News
Hosted on MSN15d
New malaria vaccine shows high protection in clinical trialThe primary endpoints were the number and severity of adverse events and the occurrence of blood-stage parasitemia (presence of parasites in the blood) exceeding 100 P. falciparum parasites per ...
Malaria parasites undergo a rapid and extensive metamorphosis after invasion of the host erythrocyte
Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...
Anti-malarial monoclonal antibodies (mAbs) are another promising new tool that has been shown to be safe and efficacious against infection with P. falciparum in adults and children in early ...
Exposing the recombinant protein to the lysate resulted in phosphorylation, which was diminished by the addition of CK2α inhibitors, indicating that both human and P. falciparum enzymes phosphorylated ...
P. falciparum is introduced into the body via a mosquito bite. The parasite grows and multiplies first in the liver, then uses human red blood cells as a nursery in which to replicate and release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results